Oric Pharmaceuticals, Inc. Common Stock
Symbol: ORIC (NASDAQ)
10.74
▲ (2.04%) 0.215
Company Description:
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
Key Stats
- Today's Open: $10.6
- Today's High: $10.914
- Today's Low: $10.303
- Today's Volume: 241.63K
- Yesterday Close: $10.52
- Yesterday High: $10.94
- Yesterday Low: $10.36
- Yesterday Volume: 1.05M
- Last Min Volume: 7.10K
- Last Min High: $10.8
- Last Min Low: $10.759
- Last Min VWAP: $10.79338
Company Profile
- Name: Oric Pharmaceuticals, Inc. Common Stock
- Website: https://www.oricpharma.com
- Listed Date: 2020-04-24
- Location: SOUTH SAN FRANCISCO, CA
- Market Status: Active
- CIK Number: 0001796280
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $1.02B
- Round Lot: 100
- Outstanding Shares: 97.12M
- Asset Type: CS
RECENT FILINGS FOR ORIC
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | SCHEDULE 13D/A | View |
| 2025-08-12 | 10-Q | View |
| 2025-08-12 | 8-K | View |
| 2025-08-05 | SCHEDULE 13G | View |
| 2025-07-17 | SCHEDULE 13G/A | View |
| 2025-07-02 | 4 | View |
| 2025-06-24 | 4 | View |
| 2025-06-24 | 424B3 | View |
| 2025-06-23 | 4 | View |
| 2025-06-20 | EFFECT | View |
| 2025-06-17 | CORRESP | View |
| 2025-06-16 | UPLOAD | View |
| 2025-06-13 | 4 | View |
| 2025-06-13 | 8-K | View |
| 2025-06-11 | 4 | View |
| 2025-06-11 | S-3 | View |
| 2025-06-09 | 4 | View |
| 2025-06-06 | 144 | View |
Latest News on ORIC